Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
82.2M
-
Shares change
-
+1.71M
-
Total reported value, excl. options
-
$2.24B
-
Value change
-
+$50.5M
-
Put/Call ratio
-
0.6
-
Number of buys
-
112
-
Number of sells
-
-105
-
Price
-
$27.25
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2023
269 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q3 2023.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.2M shares
of 106M outstanding shares and own 77.62% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.2M shares), VANGUARD GROUP INC (9.3M shares), INGALLS & SNYDER LLC (8.34M shares), RENAISSANCE TECHNOLOGIES LLC (6.61M shares), Parallel Advisors, LLC (3.72M shares), Novo Holdings A/S (3.38M shares), STATE STREET CORP (3.14M shares), DIMENSIONAL FUND ADVISORS LP (2.31M shares), GEODE CAPITAL MANAGEMENT, LLC (1.96M shares), and Boston Trust Walden Corp (1.83M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.